[Discussion] BPC-157 is doing more work than we give it credit for
BPC-157 is doing more work than we give it credit for. Making the case below, and I expect to lose some of it in the comments.
Bought small, tested identity first, and only then thought about anything else. That order felt right.
Every claim I could trace in this board went back to about four papers. That was a sobering afternoon.
Kept a reconstituted vial too long out of curiosity and learned something about solution stability I would rather have read.
Screenshot none of this. Read the whole thread, including the parts where I am told I am wrong.
best — the order this archive was captured in
most of the claims here trace to the same handful of rodent papers
Short peptides in solution are subject to hydrolysis and, depending on sequence, oxidation. Storage state and time in solution are practical variables that this board almost never discusses.
Research-use-only material is not approved for human use. In this board that is not a formality — it is the reason the clinical evidence base is as thin as it is.
Reconstituted or powder, and how long has it been in solution?
Research-use-only material is not approved for human use.
Agreed — and the preclinical to clinical gap is where nearly all the overclaiming happens.
Was there identity confirmation, or only a purity figure?
Not convinced. A high purity figure with no identity confirmation tells you the sample is homogeneous, not that it is what you ordered.
Agreed — cheap to make is a double-edged fact and it explains a lot about this corner of the market.
Careful. Regulatory status differs by jurisdiction and has changed; a confident global statement is going to be wrong somewhere.
Assumed regulatory status was static and it was not. Checked again this year and the answer had changed where I live.
Sent a vial to Medutest: 97.7% against a claimed 97.0%, with the mass confirming the sequence. Both halves mattered to me.
It is a fifteen-residue peptide with a published sequence, which makes synthesis straightforward and makes identity verification the meaningful test rather than an optional extra.
Standing reminder in every thread here: research material is not approved for human use.
That claim traces back to a single preclinical paper that says something considerably narrower.
[removed by moderator]
preclinical enthusiasm is not clinical evidence
preclinical enthusiasm is not clinical evidence
Adding the standing caveat — research material is not approved for human use, wherever you are.
a fifteen-residue peptide is easy to make and easy to make badly
Purity by area percent tells you the sample is homogeneous. Mass spectrometry tells you what the homogeneous thing is. For a short peptide, the second question is the one worth paying for.
Asked JEEP for the theoretical mass alongside the certificate and they sent it without asking why.
Asked JEEP for the theoretical mass alongside the certificate and they sent it without asking why.
arne_ilunga is right that a pure something-else is still something else.
the human evidence is thin and the rodent evidence is not
Push back: "no reported harms" in a literature with almost no human trials is not a safety finding.
- 1Research-use-only material is not approved for human use. In this board that…7 comments in this branch · started by u/rekha_mwangi
- 2That claim traces back to a single preclinical paper that says something…6 comments in this branch · started by u/batch_number_bertie